American Association of Oral and Maxillofacial Surgeons' position paper on medication-related osteonecrosis of the jaws—2022 update
SL Ruggiero, TB Dodson, T Aghaloo… - Journal of oral and …, 2022 - Elsevier
Strategies for management of patients with, or at risk for, medication-related osteonecrosis of
the jaws (MRONJ)–formerly referred to as bisphosphonate-related osteonecrosis of the jaws …
the jaws (MRONJ)–formerly referred to as bisphosphonate-related osteonecrosis of the jaws …
[PDF][PDF] Fibrous Dysplasia/McCune-Albright Syndrome: A Rare, Mosaic Disease of Gα s Activation
AM Boyce, MT Collins - Endocrine reviews, 2020 - academic.oup.com
Abstract Fibrous dysplasia/McCune-Albright syndrome (FD/MAS) is a rare disorder of
striking complexity. It arises from somatic, gain-of-function mutations in GNAS, leading to …
striking complexity. It arises from somatic, gain-of-function mutations in GNAS, leading to …
Safety and efficacy of denosumab for fibrous dysplasia of bone
Safety and Efficacy of Denosumab for Fibrous Dysplasia of Bone | New England Journal of
Medicine Skip to main content The New England Journal of Medicine homepage Advanced …
Medicine Skip to main content The New England Journal of Medicine homepage Advanced …
[HTML][HTML] Fibrous dysplasia/mccune-albright syndrome
Fibrous dysplasia/McCune-Albright syndrome (FD/MAS), the result of an early embryonic
postzygotic somatic activating pathogenic variant in GNAS (encoding the cAMP pathway …
postzygotic somatic activating pathogenic variant in GNAS (encoding the cAMP pathway …
The clinical spectrum of McCune-Albright syndrome and its management
T Spencer, KS Pan, MT Collins… - Hormone research in …, 2020 - karger.com
McCune-Albright syndrome (MAS) is a rare, mosaic disorder presenting along a broad
clinical spectrum. Disease arises from somatic-activating GNAS mutations, leading to …
clinical spectrum. Disease arises from somatic-activating GNAS mutations, leading to …
Fibrous dysplasia of bone and McCune–Albright syndrome: a bench to bedside review
Fibrous dysplasia is an uncommon mosaic disorder in which bone is replaced by structurally
unsound fibro-osseous tissue. It is caused by the sporadic post-zygotic activating mutations …
unsound fibro-osseous tissue. It is caused by the sporadic post-zygotic activating mutations …
A rare skeletal disorder, fibrous dysplasia: a review of its pathogenesis and therapeutic prospects
HY Kim, JH Shim, CY Heo - International Journal of Molecular Sciences, 2023 - mdpi.com
Fibrous dysplasia (FD) is a rare, non-hereditary skeletal disorder characterized by its chronic
course of non-neoplastic fibrous tissue buildup in place of healthy bone. A myriad of factors …
course of non-neoplastic fibrous tissue buildup in place of healthy bone. A myriad of factors …
[HTML][HTML] COVID-19 pandemic and osteoporosis in elderly patients
J Tang - Aging and disease, 2022 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19), which is caused by an infection of severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is rapidly becoming a worldwide …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is rapidly becoming a worldwide …
Denosumab in patients with fibrous dysplasia previously treated with bisphosphonates
BCJ Majoor, SE Papapoulos… - The Journal of …, 2019 - academic.oup.com
Abstract Context Fibrous dysplasia/McCune-Albright syndrome (FD/MAS) is a rare bone
disorder commonly treated with bisphosphonates, but clinical and biochemical responses …
disorder commonly treated with bisphosphonates, but clinical and biochemical responses …
The roles of RANK/RANKL/OPG in cardiac, skeletal, and smooth muscles in health and disease
L Marcadet, Z Bouredji, A Argaw… - Frontiers in Cell and …, 2022 - frontiersin.org
Although their physiology and functions are very different, bones, skeletal and smooth
muscles, as well as the heart have the same embryonic origin. Skeletal muscles and bones …
muscles, as well as the heart have the same embryonic origin. Skeletal muscles and bones …